Miracle Mile Advisors’s Altimmune ALT Stock Holding History

Miracle Mile Advisors’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$52.4K	Sell	17,000 -20	-0.1%	-$85	﹤0.01%	886
2025 Q4	$61.4K	Hold	17,020	–	–	﹤0.01%	858
2025 Q3	$64.2K	Sell	17,020 -19	-0.1%	-$73	﹤0.01%	815
2025 Q2	$65.9K	Buy	17,039 +39	+0.2%	+$211	﹤0.01%	712
2025 Q1	$85K	Hold	17,000	–	–	﹤0.01%	634
2024 Q4	$123K	Hold	17,000	–	–	﹤0.01%	617
2024 Q3	$104K	Hold	17,000	–	–	﹤0.01%	510
2024 Q2	$113K	Hold	17,000	–	–	﹤0.01%	482
2024 Q1	$173K	Hold	17,000	–	–	﹤0.01%	481
2023 Q4	$191K	Hold	17,000	–	–	0.01%	465
2023 Q3	$44.2K	Buy	+17,000	New	+$48.8K	﹤0.01%	476

Other funds holding ALT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Miracle Mile Advisors's ALT Position: Q1 2026 in Review

Miracle Mile Advisors reduced its Altimmune (ALT) stake by 0.12% in Q1 2026, selling an estimated $85 and leaving 17,000 shares worth $52.4K. The position accounts for ﹤0.01% of the portfolio, ranked #886.

Miracle Mile Advisors first reported a position in ALT in Q3 2023 and has held it in 11 quarters since. The position peaked at $191K in Q4 2023. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

Miracle Mile Advisors held 17,000 shares of Altimmune worth $52.4K as of Q1 2026.
Miracle Mile Advisors sold 20 Altimmune shares in Q1 2026, an estimated $85.
Altimmune made up ﹤0.01% of Miracle Mile Advisors's portfolio in Q1 2026, its #886 holding.
Miracle Mile Advisors first reported a position in Altimmune in Q3 2023 and has held it in 11 quarters since.
Miracle Mile Advisors's Altimmune position peaked at $191K in Q4 2023.
173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Miracle Mile Advisors's 13F filing for Q1 2026, filed 8 Apr 2026.